International Council on Nanotechnology

ICON Web & News Virtual Journal Everything

Resources
	Virtual Journal
	Analyze Database
	GoodNanoGuide
	ICON Reports
	ICON Backgrounders
	Glossary
	Policy Reports
	Ratings Comment Guidelines
	Links

Quick Search:
Keywords: Search: Search Using OECD Database

Details

Return to Previous Page

Addition or Correction

Title:

The Use of Nanoparticles as Contrast Media in Neuroimaging: A Statement on Toxicity

Date:

12/2012

Link to Journal Abstract

Abstract:

The use of nanoparticles in diagnostic imaging is rapidly gaining utility and acceptance. A handful of iron oxide nanoparticle compounds have already been approved by the U.S. Food and Drug Administration for clinical use with a favorable acute safety profile. However, because use of these agents is still in its early stages, long-term clinical data has yet to become readily available. The ability of these particles to interact with cellular biology at a molecular level does have theoretical injurious potential. As with any medical intervention, its relative risks must be clearly understood. This article discusses the safety profile and potential toxicities of nanoparticles as used in diagnostic imaging, and serves to inform the prescribing physician of relative and potential risk to the patient.

Non-technical Summary:

This article discusses the safety profile and potential toxicities of nanoparticles as used in diagnostic imaging, and serves to inform the prescribing physician of relative and potential risk to the patient.

Content Emphasis

Peer Reviewed Journal Article

Exposure Or Hazard Target

Exposure Pathway

Method Of Study

Paper Type

Particle Type